Salona Global Announces Large International Order from Polish Distributor Expected to be Delivered in the Current Quarter; Increases Year-over-Year Revenues 157% For the Polish Market
PremiumPress ReleasesSalona Global Announces Appointment of Lana Newishy to Board of Directors as Vice Chair and Enters into Financial Consulting Agreement
Salona Global Closes Acquisition of Arrowhead Medical, Provides Update on Biodex Integration; Posts First Quarter Results with Positive Adjusted EBITDA, 23% Annual Revenue Growth and 27% Growth in Annual Gross Profits, Improved Quarter-over-Quarter Gross Profit from 33.1% to 38%
Salona Global Focuses on US Capital Markets for 2023; Changes Fiscal Year End to December 31, 2022 to Prepare for US Listing; Withdraws Canadian Debenture Offering